Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

The introduction of tyrosine kinase inhibitors (TKIs) has changed the treatment paradigm of chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML patients, who now have a nearly normal life expectancy and, in some selected cases, the possibility of aiming for the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Iezza, Miriam, Cortesi, Sofia, Ottaviani, Emanuela, Mancini, Manuela, Venturi, Claudia, Monaldi, Cecilia, De Santis, Sara, Testoni, Nicoletta, Soverini, Simona, Rosti, Gianantonio, Cavo, Michele, Castagnetti, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341256/
https://www.ncbi.nlm.nih.gov/pubmed/37443737
http://dx.doi.org/10.3390/cells12131703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341256/
https://www.ncbi.nlm.nih.gov/pubmed/37443737
http://dx.doi.org/10.3390/cells12131703

Ejemplares similares